Catalog Advanced Search

Search by Categories
Search in Packages
Search by Format
Search by Type
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Keyword
Sort By
  • 201-19: Managing Pharmacologic Treatment for Older Adults: Benzodiazepines and Antipsychotics

    Contains 5 Component(s), Includes Credits

    Presenter: Elizabeth Galik, PhD, CRNP, FAAN, FAANP 1.5 pharmacology contact hours

    201-19:  Managing Pharmacologic Treatment for Older Adults:  Benzodiazepines and Antipsychotics

    Focus on deprescribing benzodiazepines and antipsychotics when managing anxiety and agitation in older adults, explore alternative pharmacological options, and understand how to use these medications appropriately and safely when necessary.


    Presenter:
       Elizabeth Galik, PhD, CRNP, FAAN, FAANP

    Disclosures:  The presenter and planners have no conflict of interest or commercial support to disclose. Off-label use of medications will be discussed during this presentation.


    Session Length:
      1 hour 31 minutes

    Target Audience:  RN, APRN


    Learning Outcomes:
    Upon completion of this presentation, the participant will be able to:

    1. Formulate treatment plans to address appropriate deprescribing practices of benzodiazepines and antipsychotics when used with older adults.
    2. Describe appropriate and safe prescribing practices of benzodiazepines and antipsychotics when used with older adults.

    Keywords:  Psychopharmacology, Older Adults, APRN Practice, Pharmacology


    Continuing Nursing Education:
    1.5 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.


    Originally Presented 
    APNA 17th Annual Clinical Psychopharmacology Institute
    Louisville, KY
    Saturday, June 8, 2019
    8:00am - 9:30am


    The contact hours for this session expire:  June 30, 2021

  • 100-19: Deep Dive into Neurotransmitters: Focus on Glutamate and Gaba

    Product not yet rated Contains 5 Component(s), Includes Credits

    Presenter: Debbie Thomas, Edd, APRN, PMHNP-BC, PMHCNS-BC, CMP 1.5 pharmacology contact hours

    100-19:  Deep Dive into Neurotransmitters: Focus on Glutamate and Gaba

    This course explores neurotransmitters, particularly glutamate and GABA, from a psychopharmacological perspective. This provides a better understanding of how this neurobiology relates to the lived experience of persons with mental health disorders.


    Presenter: 
    Debbie Thomas, Edd, APRN, PMHNP-BC, PMHCNS-BC, CMP

    Disclosures: The speaker has indicated a significant financial interest or other affiliation with Assurex Health, Inc. and Allergan, Inc. Off-label uses will not be discussed during this presentation. The activity planners have no conflicts of interest to disclose.


    Session Length:
      1 hour 25 minutes

    Target Audience:  RN, APRN


    Learning Outcomes:
    Upon completion of this presentation, the participant will be able to:

    1. Describe the basic difference in the major neurotransmitters in mental health.
    2. Explain how GABA and glutamate play a role in mental health disorders from a humanistic patient perspective.

    Keywords:  Neurotransmitters, Psychopharmacology


    Continuing Nursing Education:
    1.5 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.


    Originally Presented
    17th Annual Clinical Psychopharmacology Institute
    Louisville, KY
    Thursday, June 6, 2019
    5:00pm - 7:00pm


    The contact hours for this session expire:  June 30, 2021

  • 101-19: New Evidence, New Delivery Methods, New Opportunities for Engaging Clients

    Contains 5 Component(s), Includes Credits

    Presenter: Rebecca S. Roma MD, MBA 1.5 pharmacology contact hours

    101-19:  New Evidence, New Delivery Methods,  New Opportunities for Engaging Clients

    Consider cutting edge scientific discoveries for treating schizophrenia. Update your background knowledge of the long-range costs, and the treatment options for this mental illness.


    Presenter:
      Rebecca S Roma MD, MBA

    Disclosures: The speaker has indicated a significant financial interest or other affiliation with Alkermes, Janssen Pharmaceuticals Inc., Neurocrine, Teva, and Otsuka America Pharmaceutical, Inc. Off-label uses will not be discussed during this presentation. The activity planners have no conflicts of interest to disclose.


    Session Length:
      1 hour 24 minutes

    Target Audience:  RN, APRN


    Learning Outcomes:
    Upon completion of this presentation, the participant will be able to:

    1. Describe the course, continuity of care, and costs of schizophrenia.
    2. Explore oral medications and LAIs in a new paradigm for treatment of schizophrenia.

    Keywords:  Psychopharmacology, Long Acting Injectables, Schizophrenia

    Continuing Nursing Education:
    1.5 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.


    Originally Presented
    17th Annual Clinical Psychopharmacology Institute
    Louisville, KY
    Friday, June 7, 2019
    8:00am - 9:30am


    The contact hours for this session expire:  June 30, 2021

  • 102-19: Complex Issues in Pediatric Psychopharmacology: Depressive & Anxiety Disorders

    Contains 5 Component(s), Includes Credits

    Presenter: Jeffrey R. Strawn, MD, FAACAP 1.5 pharmacology contact hours

    102-19:  Complex Issues in Pediatric Psychopharmacology: Depressive & Anxiety Disorders

    This course explores a wealth of data and strategy to inform prescribing practices for children and adolescents with depressive and anxiety disorders. Through antidepressant efficacy and tolerability data, gain insight into how to best meet the pharmacological needs of this pediatric population.


    Presenter:  Jeffrey R. Strawn, MD, FAACAP 

    Disclosures: The speaker has indicated a significant financial interest or affiliation with Myriad/Assurex , CMEology, Kansas University, Current Psychiatry, and  Springer Publishing. The speaker also receives research funding from NIH, Allergan, Neuronetics, Shire, Edgemont and the Yung Family Foundation. Off-label use of medications will be discussed during this presentation.The activity planners have no conflicts of interest to disclose.


    Session Length:
      1 Hour 24 minutes

    Target Audience:  RN, APRN


    Learning Outcomes:
    Upon completion of this presentation, the participant will be able to:

    1. Describe differences in efficacy and tolerability among antidepressant medications in pediatric patients with anxiety disorders.
    2. Describe individual differences in SSRI metabolism and exposure in pediatric patients and dosing implications.

    Keywords:  Psychopharmacology, Pediatrics


    Continuing Nursing Education:
    1.5 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.


    Originally Presented
    17th Annual Clinical Psychopharmacology Institute
    Louisville, KY
    Friday, June 7, 2019
    9:45am - 11:15am


    The contact hours for this session expire:  June 30, 2021

  • 104-19: Sexuality and Psychotropics

    Product not yet rated Contains 5 Component(s), Includes Credits

    Presenter: Sattaria Dilks, DNP, APRN, PMHNP-BC 1.5 pharmacology contact hours

    104-19:  Sexuality and Psychotropics

    This presentation includes a candid discussion of the sexual side effects of psychotropic and non-psychotropic medications, that may interfere with consumer willingness to continue treatment. Hear eye opening cases to improve understanding and communication with the clients you serve.


    Presenter:   Sattaria Dilks, DNP, APRN, PMHNP-BC

    Disclosures:  The presenter has indicated a significant financial interest or other affiliation with Otsuka Speaker Bureau. Off-label use of medications will be discussed during this presentation.The activity planners have no conflicts of interest to disclose.


    Session Length:
      1 hour 22 minutes

    Target Audience:  RN, APRN


    Learning Outcomes:
    Upon completion of this presentation, the participant will be able to:

    1. Discuss the impact of mental illness and commonly used psychiatric medications on sexuality. 
    2. Examine prescribing considerations related to psychiatric medications and adverse sexual issues and potential solutions to minimize pharmacologically based sexual issues.

    Keywords:  Psychopharmacology, Side Effects


    Continuing Nursing Education:
    1.5 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.


    Originally Presented
    17th Annual Clinical Psychopharmacology Institute
    Louisville, KY
    Friday, June 7, 2019
    1:45pm - 3:15pm


    The contact hours for this session expire:  June 30, 2021

  • 105-19: Ethical Considerations in Psychopharmacology

    Contains 5 Component(s), Includes Credits

    Presenters: Douglas P. Olsen, PhD, RN; Barbara Limandri, PhD, PMHCNS-BC; Barbara Jones Warren, PhD, RN, PMHCNS-BC, FNAP, FAAN 1.5 pharmacology contact hours

    105-19:  Ethical Considerations in Psychopharmacology

    Discuss ethical considerations in psychopharmacological clinical practice with three nursing experts. Use an ethical decision-making framework to help navigate ethical dilemmas encountered by psychiatric-mental health nurses in clinical practice.


    Presenters:  Douglas P. Olsen, PhD, RN; Barbara Limandri, PhD, PMHCNS-BC; Barbara Jones Warren, PhD, RN, PMHCNS-BC, FNAP, FAAN

    Disclosures: The speaker has indicated a significant financial interest or affiliation with Pfizer, and Johnson & Johnson. Off-label use of medications will not be discussed during this presentation.The activity planners have no conflict of interest to disclose.


    Session Length:
      1 hour 26 minutes

    Target Audience:  RN, APRN


    Learning Outcomes:
    Upon completion of this presentation, the participant will be able to:

    1. Apply analytic techniques to different types of ethical dilemmas.
    2. Describe the basics of ethical prescribing including responsible practice, values identification, relational considerations with patients and industry, and issues of professional identity.

    Keywords:  Ethics, Decision Making

    Continuing Nursing Education:
    1.5 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.


    Originally Presented
    17th Annual Clinical Psychopharmacology Institute
    Louisville, KY
    Friday, June 7, 2019
    3:30pm - 5:00pm


    The contact hours for this session expire:  June 30, 2021

  • 106-19: 2019 CPI Friday Outcomes Panel

    Product not yet rated Contains 5 Component(s), Includes Credits

    Presenters: Barbara J. Limandri, PhD, PMHCNS-BC; Mary Ann Nihart, MA, APRN, PMHCNS-BC, PMHNP-BC; Brittany Yates, DNP, APRN, PMHNP-BC; Nick Guenzel, PhD, APRN-NP 0.5 pharmacology contact hours

    106-19:  2019 CPI Friday Outcomes Panel 

    In this panel, CPI Program Committee members will lead you through discussions about how the information in today’s sessions relate to your practice. They will also address questions submitted by attendees during the sessions. Through case study examples, information from the day will be highlighted and applied to psychopharmacologic nursing practice. These discussions will enable you to feel confident taking home new approaches for educating and providing care to your patients to ensure the best possible outcomes.


    Presenters:
      Barbara J. Limandri, PhD, PMHCNS-BC; Mary Ann Nihart, MA, APRN, PMHCNS-BC, PMHNP-BC; Brittany Yates, DNP, APRN, PMHNP-BC; Nick Guenzel, PhD, APRN-NP

    Disclosures: Speaker Limandri has indicated an affiliation with the Journal of Psychosocial Nursing, and the American Psychiatric Nurses Association. The other panel speakers have no conflict of interest or commercial support to disclose. Off-label use of medications will not be discussed during this presentation.The activity planners have no conflict of interest to disclose.

     

    Session Length:  28 minutes

    Target Audience:  RN, APRN


    Learning Outcomes:
    Upon completion of this presentation, the participant will be able to:

    1. Synthesize concepts and knowledge delivered in the presentations throughout the day.
    2. Discuss applications of the information presented to nursing psychopharmacologic practice. 

    Keywords:   APRN Practice, Case Study


    Continuing Nursing Education:
    0.5 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.


    Originally Presented
    17th Annual Clinical Psychopharmacology Institute
    Louisville, KY
    Friday, June 7, 2019
    5:00pm - 5:30pm


    The contact hours for this session expire:  June 30, 2021

  • 2019 Competency Based Training for Conducting the One Hour Face-to-Face Assessment for Patients in Restraints or Seclusion

    Contains 6 Component(s), Includes Credits

    Presenters: Marlene Nadler-Moodie, MSN, APRN, PMHCNS-BC; Pamela Greene, PhD, RN 1.5 contact hours

    2019 Competency Based Training for Conducting the One Hour Face to Face Assessment of a Patient in a Restraint or Seclusion (September 2017)

    This activity will provide the key components for assessing a patient placed in restraint or seclusion as a result of behavior that may be dangerous to self or others. Attention will be paid to the parameters set forth by the regulatory bodies. These will include, surveillance of the immediate situation, evaluation of the patient’s reactions to the restraint or seclusion implementation, assessment of the medical and behavioral condition of the patient, and determining the need to continue or terminate the restraint or seclusion.  Additionally, there will be a discussion of four key assessment elements including physical risks for loss of life, physical dangers and discomforts, the patient’s mental status, and legal and ethical considerations.

    Presenters: Marlene Nadler-Moodie, MSN, APRN, PMHCNS-BC;  Pamela Greene, PhD, RN

    Disclosures: The speakers have no conflict of interests or commercial support to disclose. Off-label uses will not be discussed during this presentation. 

    Session Length: 62 minutes

    Target Audience: RN, APRN 

    Learning Outcome: Upon completion of this presentation, the learner will successfully complete an effective Face to Face assessment of a patient in seclusion or restraint.

    Learning Objectives:
    Upon completion of this presentation, the participant will be able to:

    1. List the key components of the one hour face to face assessment of a patient in a restraint or seclusion.
    2. Describe the potential dangers associated with the use of restraint or seclusion. 
    3. Discuss the importance of assessing a patient in restraint or seclusion. 

    Keywords: Safety, Inpatient, Seclusion, Restraint, Assessment, Debriefing

    Nursing Continuing Professional Development
    1.5 contact hours. *In order to receive contact hours, you must:  Review the APNA Seclusion and Restraint position paper, listen to the entire session, complete an evaluation, and earn a passing score of 80% or better on the post-test before the expiration date. You will have 5 tries to earn a passing score on the post test. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. We cannot award credit unless all steps are completed.

    The American Psychiatric Nurses Association is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

    Release Date: September 1, 2017
    The contact hours for this session expire: May 1, 2020

  • Medication Assisted Treatment (MAT): 8-Hour Waiver Training

    Contains 36 Component(s), Includes Credits

    8.0 contact hours in pharmacology

    image









    Course Description: 

    image

    This course is jointly provided by PCSS-MAT and APNA. The course consists of 10 modules (8 hours) of the required 24 hours of content for nurses who wish to offer medication assisted treatment for opioid use disorders including buprenorphine. Sessions include webinars with case studies, an overall post-test and evaluation of the content.

    Target Audience: APRN


    Learning Outcomes:

    Upon completion of the course, learners will be able to:

    1. Describe foundational practices in medication assisted treatment including buprenorphine in order to decrease opioid use and opioid related deaths in the United States.
    2. Discuss issues related to the assessment and medication assisted treatment of persons with opioid use disorders.
    3. Articulate the role, responsibilities and limitations of a provider as described in current regulations related to medication assisted treatment for persons with opioid use disorders. 

    Continuing Education Credit:
    8.0 contact hours in pharmacology. *In order to receive contact hours for the program, participants must: View the program in its entirety (modules 1-10), earn a passing score of at least 80% on the post-test, and complete the final evaluation during the allotted 90-day access period. Participants will have 5 opportunities to correctly answer the questions on the post-tests. Following completion of the modules, post-test and evaluation the certificate will be generated online, available for immediate printing. Credit will not be awarded unless all components of the program are completed. Partial credit will not be awarded.

    Pricing: Free


    Ready to get started? 

    • The course is free of charge and can be accessed by clicking the Register button above. You will be prompted to login with your APNA account information*. If you do not have an APNA account, select the radio button, "new user to the site without an account" and complete the listed information to create a free non-member profile. Complete the check-out process to order the session for $0.
    • Complete presentations, post-test, evaluations, and receive the CNE certificate.
    • Return to the PCSS-MAT website to receive your certification of completion. DEA waiver instructions are provided upon completion of all 24 hours of training.
    • Click here for the "Steps to Obtain Your MAT Waiver" process map.

    *Note:  Membership in APNA is not required to take this course, however you will need to create an APNA account in order to access the course and earn contact hours.


    The American Psychiatric Nurses Association is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

    Accreditation of the continuing education activity does not imply endorsement by APNA or ANCC of any commercial products discussed in the context of this activity. 


    Support for the Program:
    Funding for this initiative was made possible (in part) by Providers' Clinical Support System for Medication Assisted Treatment (grant no. 1U79TI026556) from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. 

    Disclosures:

    • The Nurse Planner and members of the planning committee have no financial relationships to disclose.
    • The faculty for this activity have no conflict or commercial interests to report. 
    • Faculty members are required to complete a conflict of interest statement in order to disclose to participants any real or potential conflict of interest related to the educational activity. Resolution of actual or potential conflict of interest is required prior to faculty participation. A faculty statement of disclosure is included within each presentation. 
    • This educational activity may contain discussion of off-label usage of drugs that are not indicated by the FDA. The American Psychiatric Nurses Association and the American Academy of Addiction Psychiatry do not recommend usage of any agent outside the FDA approved/labeled indications.


    Release Date: April 21, 2017 
    The contact hours for this session expire: May 1, 2020 

  • 1015-17: Treating Nicotine and Tobacco Dependence: Assumptions That Could be Harmful to Your Patients

    Contains 5 Component(s), Includes Credits

    Presenter: Carol Essenmacher, PMHCNS-BC, DNP, CTTS 1.25 pharmacology contact hours

    1015-17: Treating Nicotine and Tobacco Dependence: Assumptions That Could be Harmful to Your Patients

    This session will provide information about tobacco dependence and treatment, with a focus on using NRT effectively, for clinicians to translate into effective interventions.

    Presenter: Carol Essenmacher, PMHCNS-BC, DNP, CTTS

    Disclosures: The presenters and planners have no conflict of interest or commercial support to disclose.  Off-label uses (using products for a purpose other than that for which it was approved by the Food and Drug Administration, or FDA) will not be discussed during this presentation.


    Session Length:
    1 hour 16 minutes

    Target Audience: RN, APRN 


    Session Objectives:

    Upon completion of this presentation, the participant will be able to:

    1. Translate knowledge of pharmacological implications of the chemical nicotine and its content in tobacco products into effective     interventions.
    2. Summarize key points about nicotine dependence and treatment implications.
    3. Demonstrate the ability to provide patients and colleagues with clarifying information on the use of other tobacco and nicotine delivery products.

    Keywords: Smoking Cessation, Tobacco Addiction, Pharmacology


    Continuing Nursing Education

    1.25 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation and earn a passing score on the post test before the expiration date. You will have 5 tries to correctly answer the questions on the post test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The American Psychiatric Nurses Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.


    Originally Presented

    APNA 15th Annual Clinical Psychopharmacology Institute
    Hyatt Regency Baltimore on the Inner Harbor
    Sunday, June 11, 2017
    2:00pm – 3:30pm

    The contact hours for this session expire: July 1, 2020